140 related articles for article (PubMed ID: 8744553)
1. Asymmetric deletion of the junction between the short unique region and the inverted repeat does not affect viral growth in culture and vaccine-induced immunity against Marek's disease.
Sonoda K; Sakaguchi M; Matsuo K; Zhu GS; Hirai K
Vaccine; 1996 Mar; 14(4):277-84. PubMed ID: 8744553
[TBL] [Abstract][Full Text] [Related]
2. Marek's disease virus protein kinase gene identified within the short unique region of the viral genome is not essential for viral replication in cell culture and vaccine-induced immunity in chickens.
Sakaguchi M; Urakawa T; Hirayama Y; Miki N; Yamamoto M; Zhu GS; Hirai K
Virology; 1993 Jul; 195(1):140-8. PubMed ID: 8391181
[TBL] [Abstract][Full Text] [Related]
3. Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site.
Sakaguchi M; Hirayama Y; Maeda H; Matsuo K; Yamamoto M; Hirai K
Vaccine; 1994 Aug; 12(10):953-7. PubMed ID: 7975837
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
5. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.
Sonoda K; Sakaguchi M; Okamura H; Yokogawa K; Tokunaga E; Tokiyoshi S; Kawaguchi Y; Hirai K
J Virol; 2000 Apr; 74(7):3217-26. PubMed ID: 10708438
[TBL] [Abstract][Full Text] [Related]
6. Insertion of tandem direct repeats consisting of avian leukosis virus LTR sequences into the inverted repeat region of Marek's disease virus type 1 DNA.
Sakaguchi M; Sonoda K; Matsuo K; Zhu GS; Hirai K
Virus Genes; 1997; 14(2):157-62. PubMed ID: 9237356
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
[TBL] [Abstract][Full Text] [Related]
8. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1.
Sakaguchi M; Nakamura H; Sonoda K; Okamura H; Yokogawa K; Matsuo K; Hira K
Vaccine; 1998 Mar; 16(5):472-9. PubMed ID: 9491501
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a Gallid herpesvirus 2 strain with novel reticuloendotheliosis virus long terminal repeat inserts.
Zhang YP; Bao KY; Sun GR; Lv HC; Cui HY; Gao YL; Wang XM; Liu CJ
Virus Genes; 2017 Jun; 53(3):386-391. PubMed ID: 28194622
[TBL] [Abstract][Full Text] [Related]
11. Retroviral sequence located in border region of short unique region and short terminal repeat of Md5 strain of Marek's disease virus type 1.
Endoh D; Ito M; Cho KO; Kon Y; Morimura T; Hayashi M; Kuwabara M
J Vet Med Sci; 1998 Feb; 60(2):227-35. PubMed ID: 9524948
[TBL] [Abstract][Full Text] [Related]
12. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
[TBL] [Abstract][Full Text] [Related]
13. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification.
Zhu GS; Ojima T; Hironaka T; Ihara T; Mizukoshi N; Kato A; Ueda S; Hirai K
Avian Dis; 1992; 36(3):637-45. PubMed ID: 1329711
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
[TBL] [Abstract][Full Text] [Related]
16. Pathotyping of Australian isolates of Marek's disease virus and association of pathogenicity with meq gene polymorphism.
Renz KG; Cooke J; Clarke N; Cheetham BF; Hussain Z; Fakhrul Islam AF; Tannock GA; Walkden-Brown SW
Avian Pathol; 2012; 41(2):161-76. PubMed ID: 22515535
[TBL] [Abstract][Full Text] [Related]
17. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
[TBL] [Abstract][Full Text] [Related]
18. Sequence determination and genetic content of an 8.9-kb restriction fragment in the short unique region and the internal inverted repeat of Marek's disease virus type 1 DNA.
Sakaguchi M; Urakawa T; Hirayama Y; Miki N; Yamamoto M; Hirai K
Virus Genes; 1992 Nov; 6(4):365-78. PubMed ID: 1282282
[TBL] [Abstract][Full Text] [Related]
19. Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Gao Y; Cui H; Qi X; Zhong L; Wang X
Vaccine; 2016 Nov; 34(47):5744-5750. PubMed ID: 27742216
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of Marek's disease virus serotype 1 (MDV1) ICP22 gene product: MDV1 ICP22 transactivates the MDV1 ICP27 promoter synergistically with MDV1 ICP4.
Kato K; Izumiya Y; Tohya Y; Takahashi E; Hirai K; Kawaguchi Y
Vet Microbiol; 2002 Apr; 85(4):305-13. PubMed ID: 11856580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
